Avanos Medical to acquire pain management innovator Diros Technology
In a decisive move to enhance its chronic pain management solutions, US-based medical technology firm Avanos Medical has announced plans to acquire Diros Technology, a ... Read More
Themis Medicare gets DGCI approval for narcotic painkiller REMITHEM
Themis Medicare has been granted approval from the Drug Controller General of India (DCGI) for importing and commercialization of Remifentanil 1 mg/2mg Powder for Concentrate ... Read More
Alembic Pharmaceuticals gets FDA final approval for Ketorolac Tromethamine
Alembic Pharmaceuticals has secured final approval for its abbreviated new drug application (ANDA) for Ketorolac Tromethamine Injection USP, 15 mg/mL, 30 mg/mL, and 60 mg/2 ... Read More
Strides Pharma gets FDA approval for Ibuprofen oral suspension
Strides Pharma Science Limited said that its stepdown fully-owned subsidiary — Strides Pharma Global Pte. Limited, Singapore, has secured approval from the US Food and ... Read More
Dr. Reddy’s, Senores launch Ketorolac Tromethamine Tablets in US
Dr. Reddy’s Laboratories and its partner Senores Pharmaceuticals have launched Ketorolac Tromethamine Tablets USP, 10 mg, in the US market. The launched product is a ... Read More
Hempsana to manufacture Cream of the Crop Terpene Rich Relief Cream
Hempsana Holdings said that it has forged a custom manufacturing deal with Cream of the Crop Therapeutics to launch the latter’s Terpene Rich formulated product. ... Read More
Cipla associate Avenue Therapeutics fails to get FDA approval for IV tramadol
Cipla’s step-down associate firm Avenue Therapeutics has failed to get approval from the US Food and Drug Administration (FDA) for IV tramadol as an alternative ... Read More
Antibe Therapeutics completes patient enrollment in OA knee pain trial for ATB-346
Antibe Therapeutics, a Canadian pharma company has completed enrollment of patients in a phase 2B dose-ranging, efficacy clinical trial of its lead drug candidate ATB-346 ... Read More
Wayne Pharmaceuticals launches Dr Wayne’s Aspirin in US
Wayne Pharmaceuticals has launched Dr Wayne’s Aspirin Tablets in the US in a bottle package containing 300 tablets, each having 81mg strength. Dr. Wayne’s Aspirin ... Read More
Alliqua BioMedical to acquire Adynxx, forming new clinical-stage pharmaceutical leader
Pennsylvania-based Alliqua BioMedical has announced a significant merger with San Francisco's Adynxx, aiming to establish a clinical-stage pharmaceutical entity dedicated to non-opioid pain management therapies. ... Read More